Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 6, 2016, Pages 1796-1806

  Gagliardo, Rosalia ^a   Gras, Delphine ^b   La Grutta, Stefania ^a   Chanez, Pascal ^b   Di Sano, Caterina ^a   Albano, Giusy D ^a   Vachier, Isabelle ^c   Montalbano, Angela M ^a   Anzalone, Giulia ^a   Bonanno, Anna ^a   Riccobono, Loredana ^a   Gjomarkaj, Mark ^a   Profita, Mirella ^a  

^a CNR   (Italy)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Med Bio Med   (France)

Author keywords

Childhood asthma; formyl peptide receptor 2 lipoxin receptor; glucocorticosteroids; induced sputum; inflammation resolution; lipoxin A4

Indexed keywords

FLUTICASONE PROPIONATE; FORMYL PEPTIDE RECEPTOR 2 LIPOXIN RECEPTOR; FORMYLPEPTIDE RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ICOSANOID; LIPOXIN A; SALBUTAMOL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CORTICOSTEROID; FPR2 PROTEIN, HUMAN; IMMUNOGLOBULIN E; LEUKOTRIENE B4; LIPOXIN; LIPOXIN RECEPTOR;

ARTICLE; ASTHMA; CELL MIGRATION; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHIL COUNT; FATTY ACID SYNTHESIS; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPUTUM LEVEL; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; IMMUNOLOGY; LEUKOCYTE; LUNG FUNCTION TEST; METABOLISM; PHOSPHORYLATION; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SKIN TEST; SPUTUM;

ADRENAL CORTEX HORMONES; ASTHMA; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTES; LEUKOTRIENE B4; LIPOXINS; MALE; PHOSPHORYLATION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, LIPOXIN; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SKIN TESTS; SPUTUM;

EID: 84960156815     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.11.045     Document Type: Article

References (49)

1. P.M. Byrne, and D.S. Postma The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group Am J Respir Crit Care Med 159 5 Pt 2 1999 S41 S63
2. S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B. Trudeau, R.L. Gibbs, and et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
3. J. Bousquet, P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola Asthma. From bronchoconstriction to airways inflammation and remodeling Am J Respir Crit Care Med 161 2000 1720 1745
4. O. Haworth, and B.D. Levy Endogenous lipid mediators in the resolution of airway inflammation Eur Respir J 30 2007 980 992
5. P.M. Henson Dampening inflammation Nat Immunol 6 2005 1179 1181
6. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
7. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostaglandins Other Lipid Mediat 68-69 2002 433 455
8. P. Maderna, and C. Godson Lipoxins: resolutionary road Br J Pharmacol 158 2009 947 959
9. 4 modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism Eur J Immunol 44 2014 357 369
10. A. Ariel, N. Chiang, M. Arita, N.A. Petasis, and C.N. Serhan Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells J Immunol 170 2003 6266 6272
11. J. Aliberti, S. Hieny, C. Reis e Sousa, C.N. Serhan, and A. Sher Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity Nat Immunol 3 2002 76 82
12. C.N. Serhan Mediator lipidomics Prostaglandins Other Lipid Mediat 77 2005 4 14
13. T. Takano, S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J Exp Med 185 1997 1693 1704
14. S. Chinthamani, O. Odusanwo, N. Mondal, J. Nelson, S. Neelamegham, and O.J. Baker Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium Am J Physiol Cell Physiol 302 2012 C968 C978
15. K. Fukunaga, P. Kohli, C. Bonnans, L.E. Fredenburgh, and B.D. Levy Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury J Immunol 174 2005 5033 5039
16. C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez Lipoxins are potential endogenous antiinflammatory mediators in asthma Am J Respir Crit Care Med 165 2002 1531 1535
17. M. Hachicha, M. Pouliot, N.A. Petasis, and C.N. Serhan Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis J Exp Med 189 1999 1923 1930
18. A.T. Gewirtz, L.S. Collier-Hyams, A.N. Young, T. Kucharzik, W.J. Guilford, J.F. Parkinson, and et al. Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J Immunol 168 2002 5260 5267
19. B.D. Levy, C. Bonnans, E.S. Silverman, L.J. Palmer, G. Marigowda, E. Israel, and et al. Diminished lipoxin biosynthesis in severe asthma Am J Respir Crit Care Med 172 2005 824 830
20. A. Planagumà, S. Kazani, G. Marigowda, O. Haworth, T.J. Mariani, E. Israel, and et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma Am J Respir Crit Care Med 178 2008 574 582
21. H. Eke Gungor, F. Tahan, S. Gokahmetoglu, and B. Saraymen Decreased levels of lipoxin A4 and annexin A1 in wheezy infants Int Arch Allergy Immunol 163 2014 193 197
22. C.J. Bossley, S. Saglani, C. Kavanagh, D.N. Payne, N. Wilson, L. Tsartsali, and et al. Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma Eur Respir J 34 2009 1052 1059
23. S. La Grutta, R. Gagliardo, F. Mirabella, G.B. Pajno, G. Bonsignore, J. Bousquet, and et al. Clinical and biological heterogeneity in children with moderate asthma Am J Respir Crit Care Med 167 2003 1490 1495
24. R. Gagliardo, S. La Grutta, P. Chanez, M. Profita, A. Paternò, F. Cibella, and et al. Non-invasive markers of airway inflammation and remodeling in childhood asthma Pediatr Allergy Immunol 20 2009 780 790
25. G.J. Wiegers, and J.M. Reul Induction of cytokine receptors by glucocorticoids: functional and pathological significance Trends Pharmacol Sci 19 1998 317 321
26. A. Hashimoto, Y. Murakami, H. Kitasato, I. Hayashi, and H. Endo Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation Biomed Pharmacother 61 2007 81 85
27. Y.S. Bae, H.J. Yi, H.Y. Lee, E.J. Jo, J.I. Kim, T.G. Lee, and et al. Differential activation of formyl peptide receptor-like 1 by peptide ligands J Immunol 171 2003 6807 6813
28. K.F. Chung, S.E. Wenzel, J.L. Brozek, A. Bush, M. Castro, P.J. Sterk, and et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 2014 343 373
29. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, and et al. Standardisation of spirometry Eur Respir J 26 2005 319 338
30. S. Dreborg Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen Allergy 48 1993 473 475
31. N. Eid, R. Morton, B. Olds, P. Clark, S. Sheikh, and S. Looney Decreased morning serum cortisol levels in fluticasone propionate Pediatrics 109 2002 217 221
32. E. Hagg, K. Asplund, and F. Lithner Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency Clin Endocrinol 26 1987 221 226
33. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, W.W. Busse, and et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
34. P.D. Jones, R. Hankin, J. Simpson, P.G. Gibson, and R.L. Henry The tolerability, safety, and success of sputum induction and combined hypertonic saline challenge in children Am J Respir Crit Care Med 164 2001 1146 1149
35. A. Efthimiadis, A. Spanevello, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, and et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur Respir J Suppl 37 2002 19s 23s
36. R. Gagliardo, P. Chanez, M. Gjomarkaj, S. La Grutta, A. Bonanno, A.M. Montalbano, and et al. The role of transforming growth factor-β1 in airway inflammation of childhood asthma Int J Immunopathol Pharmacol 26 2013 725 738
37. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 2001 612 619
38. B.D. Levy, G.T. De Sanctis, P.R. Devchand, E. Kim, K. Ackerman, B.A. Schmidt, and et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4) Nat Med 8 2002 1018 1023
39. I. Vachier, C. Bonnans, C. Chavis, M. Farce, P. Godard, J. Bousquet, and et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound J Allergy Clin Immunol 115 2005 55 60
40. S.H. Wu, P.L. Yin, Y.M. Zhang, and H.X. Tao Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree Pediatr Pulmonol 45 2010 333 340
41. S. Fiore, J.F. Maddox, H.D. Perez, and C.N. Serhan Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor J Exp Med 180 1994 253 260
42. M. Bäck, W.S. Powell, S.E. Dahlén, J.M. Drazen, J.F. Evans, C.N. Serhan, and et al. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 Br J Pharmacol 171 2014 3551 3574
43. V. Starosta, K. Pazdrak, I. Boldogh, T. Svider, and A. Kurosky Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes J Immunol 181 2008 8688 8699
44. C. Barnig, M. Cernadas, S. Dutile, X. Liu, M.A. Perrella, S. Kazani, and et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma Sci Transl Med 5 2013 174ra26
45. M. Perretti, and F. D'Acquisto Annexin A1 and glucocorticoids as effectors of the resolution of inflammation Nat Rev Immunol 9 2009 62 70
46. P. Sawmynaden, and M. Perretti Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes Biochem Biophys Res Commun 349 2006 1351 1355
47. A.L. Miller, M.S. Webb, A.J. Copik, Y. Wang, B.H. Johnson, R. Kumar, and et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211 Mol Endocrinol 19 2005 1569 1583
48. W. Chen, T. Dang, R.D. Blind, Z. Wang, C.N. Cavasotto, A.B. Hittelman, and et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression Mol Endocrinol 22 2008 1754 1766
49. R.H. Oakley, and J.A. Cidlowski The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease J Allergy Clin Immunol 132 2013 1033 1044